{
    "root": "db147c65-ed03-4af5-af1f-86b9ff51148a",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Eysuvis",
    "value": "20250311",
    "ingredients": [
        {
            "name": "LOTEPREDNOL ETABONATE",
            "code": "YEH1EZ96K6"
        }
    ],
    "indications": "EYSUVIS is a corticosteroid indicated for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease.",
    "contraindications": "Shake for two to three seconds before using. ( 2 ) Instill one to two drops of EYSUVIS into each eye four times daily.  ( 2 )",
    "warningsAndPrecautions": "EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% is a sterile ophthalmic suspension. It is supplied in a white, low-density polyethylene dropper bottle with a linear low-density polyethylene tip, a pink high-density polyethylene cap, and a white low-density polyethylene tamper-evident overcap in the following size:\n                  8.3 mL in a 10 mL bottle (NDC 71571-333-83)\n                  \n                     Storage and Handling\n                  \n                  Do not use if tamper-evident overcap seal is not intact.\n                  The white tamper-evident overcap can be thrown away. Retain the pink cap and keep the bottle tightly closed when not in use.\n                  Store upright at 15째C to 25째C (59째F to 77째F). Do not freeze. After opening, EYSUVIS can be used until the expiration date on the bottle.",
    "adverseReactions": "EYSUVIS, as with other ophthalmic corticosteroids, is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures."
}